Medical & Bio Strategy Weekly Report– category –

Vol. 57 | 2026.09.07 — 09.13 | Market Mood: 78 / 100 — Optimistic The medical and bio domain is undergoing a transformative period marked by biotech industrialization and precision health. Automation, AI, and advanced...

Vol. 56 | 2026.08.31 — 09.06 | Market Mood: 68 / 100 — Cautious Optimism Biotech's dual trajectory continues with breakthroughs in cell & gene therapies, evidenced by 3 FDA approvals, and AI-driven drug discovery, wit...

Vol. 55 | 2026.08.24 — 08.30 | Market Mood: 78 / 100 — Optimistic AI and gene editing are revolutionizing the Medical & Bio landscape. This week spotlights significant advances: AI-driven bio-innovation fuels 75 clini...

Vol. 55 | 2026.08.17 — 08.23 | Market Mood: 78 / 100 — Optimistic Biotech innovation accelerates: advanced therapies, AI-driven discovery, and real-time diagnostics converge to reshape medical and bio industries. Rapi...

Vol. 49 | 2026.08.10 — 08.16 | Market Mood: 85 / 100 — Optimistic Biopharma innovation accelerates, driven by AI, advanced cell therapies, and precision delivery. This era sees AI platforms compressing drug discovery ...

Vol. 49 | 2026.07.27 — 08.02 | Market Mood: 75 / 100 — Optimistic The 'Medical & Bio' domain is undergoing unprecedented transformation, marked by a powerful convergence of biotech innovation and digital health. Advan...

Vol. 1 | 2026.07.20 — 07.26 | Market Mood: 78 / 100 — Optimistic Biotech innovation is accelerating as advanced therapies, AI-driven discovery, and precision diagnostics converge to reshape medical industries. Automat...

Vol. 49 | 2026.07.13 — 07.19 | Market Mood: 78 / 100 — Optimistic Precision medicine accelerates, fueled by converging AI and advanced biologics. This week validates AI's clinical impact, with 2 drug candidates enteri...

Vol. 49 | 2026.07.06 — 07.12 | Market Mood: 80 / 100 — Optimistic Precision Medicine stands at a pivotal frontier. This report dissects the convergence of advanced cell therapies, AI-driven drug discovery, and real-time biosensing, redef...

Vol. 49 | 2026.06.29 — 07.05 | Market Mood: 78 / 100 — Optimistic Our intelligence report, "AI-Driven Biopharma Acceleration," explores how AI, advanced manufacturing, and precision diagnostics are reshaping Medical &...